Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins

被引:92
作者
Yang, CY
Raya, JL
Chen, HH
Chen, CH
Abe, Y
Pownall, HJ
Taylor, AA
Smith, CV
机构
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA
[3] Ohio State Univ, Childrens Res Inst, Ctr Dev Pharmacol & Toxicol, Columbus, OH 43210 USA
关键词
oxidized LDL; atherosclerosis; hypercholesterolemia; DNA synthesis; adhesion molecule induction;
D O I
10.1161/01.ATV.0000071350.78872.C4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Current evidence suggests that oxidatively modified human plasma low-density lipoproteins (ox-LDLs) are proatherogenic and cytotoxic to endothelial and vascular smooth muscle cells. The present study describes a method using ion-exchange chromatography that is capable of large-scale subfractionation of LDL for adequate analyses of composition or bioactivities. Methods and Results-LDLs from normolipidemic (N-LDL) and homozygous familial hypercholesterolemic (FH-LDL) subjects were separated into 5 subfractions (L1 through L5) by high-capacity ion-exchange chromatography. The most strongly retained fraction from FH subjects, FH-L5, suppressed DNA synthesis in cultured bovine aortic endothelial cells and stimulated mononuclear cell adhesion to cultured endothelial cells under flow conditions in vitro. L5, which represented 1.1 +/- 0.2% and 3.7 +/- 1.7% of the LDL from N-LDL and FH-LDL, respectively, was more triglyceride-rich (17% versus 5%) and cholesteryl ester-poor (23% versus 33%) than were L1 through L4. Electrophoretic mobilities on agarose gels increased from L1 to L5. According to SDS-PAGE, apolipoprotein B-100 in N-LDL fractions L1 through L5 appeared as a single approximate to500-kDa band. In contrast, the fractions isolated from FH-LDL showed substantial fragmentation of the apolipoprotein B-100, including bands between 200 and 116 kDa. Competitive ELISA analyses using a malondialdehyde-specific monoclonal antibody against Cu2+ ox-LDL suggest that FH-L5 is malondialdehyde-modified. Conclusions-Relative to N-LDL, FH-LDL contains higher concentrations of a fraction, L5, that exhibits distinctive physicochemical properties and biological activities that may contribute to initiation and progression of atherogenesis in vivo.
引用
收藏
页码:1083 / 1090
页数:8
相关论文
共 38 条
  • [1] Abe Y, 1996, J IMMUNOL, V157, P5061
  • [2] [Anonymous], 1995, FAMILIAL HYPERCHOLES
  • [3] PRESENCE OF A MODIFIED LOW-DENSITY LIPOPROTEIN IN HUMANS
    AVOGARO, P
    BON, GB
    CAZZOLATO, G
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 79 - 87
  • [4] ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS
    BERLINER, JA
    NAVAB, M
    FOGELMAN, AM
    FRANK, JS
    DEMER, LL
    EDWARDS, PA
    WATSON, AD
    LUSIS, AJ
    [J]. CIRCULATION, 1995, 91 (09) : 2488 - 2496
  • [5] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS
    BERLINER, JA
    TERRITO, MC
    SEVANIAN, A
    RAMIN, S
    KIM, JA
    BAMSHAD, B
    ESTERSON, M
    FOGELMAN, AM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) : 1260 - 1266
  • [6] Burns AR, 1997, J IMMUNOL, V159, P2893
  • [7] Inhibitory effects of hypercholesterolemia and Ox-LDL on angiogenesis-like endothelial growth in rabbit aortic explants - Essential role of basic fibroblast growth factor
    Chen, CH
    Cartwright, J
    Li, Z
    Leu, S
    Nguyen, HH
    Gotto, AM
    Henry, PD
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (07) : 1303 - 1312
  • [8] Chen CH, 2001, CIRCULATION, V104, P297
  • [9] Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression
    Chen, CH
    Jiang, W
    Via, DP
    Luo, S
    Li, TR
    Lee, YT
    Henry, PD
    [J]. CIRCULATION, 2000, 101 (02) : 171 - 177
  • [10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497